Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

RESMED INC Director's Dealing 2017

Aug 21, 2017

30071_dirs_2017-08-21_c55e8379-89f0-4df5-9a3b-3f46ba46efc6.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: RESMED INC (RMD)
CIK: 0000943819
Period of Report: 2017-08-17

Reporting Person: PENDARVIS DAVID (Chief Administrative Officer)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2017-08-17 ResMed Common Stock A 7253 Acquired 85365 Direct
2017-08-17 ResMed Common Stock A 1443 Acquired 86808 Direct

Footnotes

F1: Represents performance-based restricted stock units granted on November 16, 2016. The shares were earned on August 17, 2017, when the compensation committee certified that the performance metrics were met. Stock units vest 1/3 each year on the anniversary of the grant.

F2: Represents performance-based restricted stock units granted on June 1, 2017. The shares were earned on August 17, 2017, when the compensation committee certified that the performance metrics were met. Stock units vest 1/3 each year on the anniversary of the grant.